Drosmark 30 is a combined oral contraceptive tablet that consists of Ethinyl Estradiol 0.03 mg and Drospirenone 3 mg. It is formulated as a trusted and once daily hormonal contraceptive for women who wants to avoid pregnancy. Manufactured under WHO and GMP certified facilities, Drosmark 30 shows the commitment towards quality and purity of Aunexis Pharmaceuticals.
Composition
Each film-coated tablet of Drosmark-30 contains:
- Ethinyl Estradiol: 0.03 mg (a synthetic estrogen)
- Drospirenone: 3 mg (a fourth-generation progestin with anti-mineralocorticoid and anti-androgenic activity)
How Drosmark-30 Works
Drosmark 30 operates through the combined action of two hormonal components. Ethinyl estradiol prevents the release of gonadotropins from the pituitary gland thus suppressing ovulation. Drospirenone helps in this by thickening the cervical mucus which prevents sperm penetration and by reducing the endometrial lining to make implantation almost impossible. Together these functioning provides reliable contraception protection when the tablet is consumed correctly and consistently.
Key Features
- Combination hormonal contraceptive with a well-studied estrogen-progestin profile
- Drospirenone offers anti-mineralocorticoid activity, which may help limit fluid retention
- Manufactured in WHO-GMP certified facilities using quality-assured raw materials
- Convenient once-daily dosing schedule
- Available in a 10×1×24 blister pack, suitable for institutional and retail distribution
Indication
Drosmark-30 is indicated for the prevention of pregnancy in women who choose oral hormonal contraception as their method of birth control.
Dosage & Administration
Drosmark-30 is intended for oral administration, one tablet daily, preferably at the same time each day, as advised by the prescribing physician. The exact regimen, starting day of the cycle, and duration of use should always be determined by a qualified healthcare professional based on the patient’s individual health profile.
Safety Information
As with all combined hormonal contraceptives, Drosmark-30 should be used only under medical supervision. It may not be suitable for women with a history of thromboembolic disorders, certain liver conditions, uncontrolled hypertension, migraine with aura, or hormone-sensitive cancers, among other contraindications. Smokers, particularly those above 35 years of age, should discuss their risk profile with a doctor before use. Common, generally mild effects can include nausea, headache, breast tenderness, or irregular spotting, especially during the first few cycles.
Frequently Asked Questions
Q. What is Drosmark-30 used for?
Drosmark-30 is a combined oral contraceptive used by women to prevent pregnancy. It contains Ethinyl Estradiol and Drospirenone, which work together to inhibit ovulation.
Q. What is the composition of Drosmark-30?
Each tablet contains Ethinyl Estradiol 0.03 mg and Drospirenone 3 mg.
Q. How should Drosmark-30 be taken?
It is typically taken once daily at the same time each day, exactly as prescribed by a doctor. Patients should not alter the dosing schedule without medical advice.
Q. Is Drosmark-30 a prescription medicine?
Yes. Drosmark-30 is a prescription-only hormonal medicine and should be used strictly under the guidance of a qualified healthcare provider.
Q. Are there any side effects of Drosmark-30?
Some women may experience mild nausea, headache, breast tenderness, mood changes, or breakthrough bleeding, particularly in the first few cycles. Any persistent or severe symptoms should be reported to a doctor promptly.
Q. Who should avoid taking Drosmark-30?
Women with a history of blood clots, certain liver disorders, uncontrolled high blood pressure, migraine with aura, hormone-sensitive cancers, or who are pregnant, should avoid this medicine unless specifically advised otherwise by a physician.
Q. Can I get Drosmark-30 for PCD franchise or bulk distribution?
Yes. Aunexis Pharmaceuticals offers Drosmark-30 for PCD pharma franchise partners and bulk/institutional buyers. Interested parties can reach out via the Contact Us page on the Aunexis Pharmaceuticals website for pricing and availability.
